Literature DB >> 26921911

Primary glomerulonephritides.

Jürgen Floege1, Kerstin Amann2.   

Abstract

Most glomerulonephritides, even the more common types, are rare diseases. They are nevertheless important since they frequently affect young people, often cannot be cured, and can lead to chronic kidney disease, including end-stage renal failure, with associated morbidity and cost. For example, in young adults, IgA nephropathy is the most common cause of end-stage renal disease. In this Seminar, we summarise existing knowledge of clinical signs, pathogenesis, prognosis, and treatment of glomerulonephritides, with a particular focus on data published between 2008 and 2015, and the most common European glomerulonephritis types, namely IgA nephropathy, membranous glomerulonephritis, minimal change disease, focal segmental glomerulosclerosis, membranoproliferative glomerulonephritis, and the rare complement-associated glomerulonephritides such as dense deposit disease and C3 glomerulonephritis.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 26921911     DOI: 10.1016/S0140-6736(16)00272-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  74 in total

1.  Urinary expression of long non-coding RNA TUG1 in non-diabetic patients with glomerulonephritides.

Authors:  Fernando Javier Salazar-Torres; Miguel Medina-Perez; Zesergio Melo; Claudia Mendoza-Cerpa; Raquel Echavarria
Journal:  Biomed Rep       Date:  2020-11-20

2.  [Acute, bilateral visual loss in a patient with IgA glomerulonephritis].

Authors:  J Ehrhardt; F Gelisken
Journal:  Ophthalmologe       Date:  2018-03       Impact factor: 1.059

Review 3.  Precision Transplant Medicine: Biomarkers to the Rescue.

Authors:  Maarten Naesens; Dany Anglicheau
Journal:  J Am Soc Nephrol       Date:  2017-10-09       Impact factor: 10.121

4.  Clinical study on Yishen Qufeng Shengshi Recipe () for glomerular proteinuria patients: A randomized controlled trial.

Authors:  Qin Dai; Pei-Qing Zhang; Xiao-Qin Wang; Li-Fang Nie; Xiao-Jun Fu; Wen Peng; Yi Wang; Jun Li; Yue-Ping Bi; Xiu-Hua Mi; Min Yuan; Li-Qun He
Journal:  Chin J Integr Med       Date:  2017-11-17       Impact factor: 1.978

Review 5.  Steroid therapy in children with IgA nephropathy.

Authors:  Alexandra Cambier; Olivia Boyer; Georges Deschenes; James Gleeson; Anne Couderc; Julien Hogan; Thomas Robert
Journal:  Pediatr Nephrol       Date:  2019-02-18       Impact factor: 3.714

Review 6.  Bone Health in Glomerular Kidney Disease.

Authors:  Dorey A Glenn; Michelle R Denburg
Journal:  Curr Osteoporos Rep       Date:  2019-12       Impact factor: 5.096

7.  [Clinical and pathological features in IgA nephropathy with IgG deposition in the glomerular mesangial area].

Authors:  Xiao-Meng Xu; Shuang-Shuang Zhu; Xiao-Hong Wang; Xiao-Fei Shao; Bin Li; Ying Zhang; Qin Liu; Jia-Min Li; Hong-Lei Wang; Yong-Qiang Li; He-Qun Zou
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-03-20

Review 8.  Minimal Change Disease.

Authors:  Marina Vivarelli; Laura Massella; Barbara Ruggiero; Francesco Emma
Journal:  Clin J Am Soc Nephrol       Date:  2016-12-09       Impact factor: 8.237

9.  Complement Component 3 Adapts the Cerebrospinal Fluid for Leptomeningeal Metastasis.

Authors:  Adrienne Boire; Yilong Zou; Jason Shieh; Danilo G Macalinao; Elena Pentsova; Joan Massagué
Journal:  Cell       Date:  2017-03-09       Impact factor: 41.582

10.  Non-infectious aortitis in an immunosuppressed renal transplant recipient with IgA nephropathy.

Authors:  Charlotte M Snead; Stephen C Crockett; Phillippa K Bailey
Journal:  BMJ Case Rep       Date:  2017-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.